
No data
No data
No data
| CAS Number | 364-98-7 |
| Catalog Number | AG0039DY(AGN-PC-0O9CRO) |
| Chemical Name | DIAZOXIDE |
| EC Number | 206-668-1 |
| IUPAC Name | 7-chloro-3-methyl-4H-1λ6,2,4-benzothiadiazine 1,1-dioxide |
| InChI | InChI=1S/C8H7ClN2O2S/c1-5-10-7-3-2-6(9)4-8(7)14(12,13)11-5/h2-4H,1H3,(H,10,11) |
| InChI Key | GDLBFKVLRPITMI-UHFFFAOYSA-N |
| MDL Number | MFCD00078578 |
| Molecular Formula | C8H7ClN2O2S |
| Molecular Weight | 230.6714 |
| SMILES | CC1=Nc2ccc(cc2S(=O)(=O)N1)Cl |
| UNII | O5CB12L4FN |
| Synonyms | Diazoxide,
Hyperstat,
Proglycem,
diazoxide,
364-98-7,
Proglycem,
Hyperstat,
Eudemine,
Hypertonalum,
Proglicem,
Dizoxide,
Mutabase,
Diazossido,
7-Chloro-3-methyl-2H-1,2,4-benzothiadiazine 1,1-dioxide,
Diazoxido,
Diazoxidum,
Sch 6783,
Sch-6783,
Diazossido [Italian],
Diazossido [DCIT],
SRG 95213,
SRG-95213,
Diazoxidum [INN-Latin],
Diazoxido [INN-Spanish],
2H-1,2,4-Benzothiadiazine, 7-chloro-3-methyl-, 1,1-dioxide,
C8H7ClN2O2S,
UNII-O5CB12L4FN,
NSC 76130,
EINECS 206-668-1,
NSC 64198,
NSC-64198,
O5CB12L4FN,
3-methyl-7-chloro-1,2,4-benzothiadiazine 1,1-dioxide,
MLS000028459,
7-Cloro-3-metil-2H-1,2,4-benzotiodiazina-1,1-diossido,
CHEBI:4495,
GDLBFKVLRPITMI-UHFFFAOYSA-N,
7-Cloro-3-metil-2H-1,2,4-benzotiodiazina-1,1-diossido [Italian],
NSC64198,
NSC76130,
MFCD00078578,
NCGC00015380-09,
CAS-364-98-7,
SMR000058392,
7-chloro-3-methyl-4H-1$l^{6},2,4-benzothiadiazine 1,1-dioxide,
DSSTox_CID_2914,
DSSTox_RID_76786,
DSSTox_GSID_22914,
7-Chloro-3-methyl-2H-1,2,4-benzothiadiazine1,1-dioxide,
7-chloro-3-methyl-4h-1,2,4-benzothiadiazine 1,1-dioxide,
Aroglycem,
7-chloro-3-methyl-4H-benzo[e][1,2,4]thiadiazine 1,1-dioxide,
Hyperstat (TN),
Diazoxide [USAN:INN:BAN],
SR-01000075314,
7-Chloro-3-methyl-2H-1,4-benzothiadiazine 1,1-dioxide,
7-chloro-3-methyl-4H-1,
Diazoxide (JAN/USP/INN),
2H-1,4-Benzothiadiazine, 7-chloro-3-methyl-, 1,1-dioxide,
7-chloro-3-methyl-2H-1?^{6},2,4-benzothiadiazine 1,1-dioxide,
Eudemine injection,
Prestwick_163,
Diazoxide [USAN:USP:INN:BAN:JAN],
Tocris-0964,
Opera_ID_608,
AC1L1EZN,
Prestwick0_000087,
Prestwick1_000087,
Prestwick2_000087,
Prestwick3_000087,
Spectrum3_000735,
Spectrum4_001248,
Lopac-D-9035,
CHEMBL181,
D 9035,
CBiol_001750,
Lopac0_000404,
SCHEMBL41254,
BSPBio_000014,
BSPBio_001307,
BSPBio_002290,
KBioGR_000027,
KBioGR_001776,
KBioSS_000027,
MLS001076071,
MLS001424164,
SPECTRUM2300206,
SPBio_001953,
BPBio1_000016,
GTPL2409,
CHEMBL1518123,
DTXSID7022914,
BDBM86248,
KBio2_000027,
KBio2_002595,
KBio2_005163,
KBio3_000053,
KBio3_000054,
KBio3_001510,
AOB5782,
Bio1_000036,
Bio1_000525,
Bio1_001014,
Bio2_000027,
Bio2_000507,
HMS1361B09,
HMS1568A16,
HMS1791B09,
HMS1922L22,
HMS1989B09,
HMS2051P20,
HMS2089L04,
HMS2093N12,
HMS2095A16,
HMS2234B23,
HMS3261A10,
HMS3267I11,
HMS3371L13,
HMS3393P20,
HMS3402B09,
HMS3675L18,
HMS3712A16,
Pharmakon1600-02300206,
2H-1,2, 4-Benzothiadiazine, 7-chloro-3-methyl-, 1,1-dioxide,
7-Chloro-3-methyl-1lambda~4~,2,4-benzothiadiazin-1-ol 1-oxide,
BCP26107,
HY-B1140,
NSC_3019,
ZINC3872277,
Tox21_110132,
Tox21_500404,
ACM364987,
BG0437,
KC-115,
NSC-76130,
NSC759574,
s4630,
AKOS015896340,
AKOS024458715,
Tox21_110132_1,
ACN-054388,
CCG-101062,
CCG-204497,
CS-4745,
DB01119,
FCH1327708,
KS-1444,
LP00404,
MCULE-5031397425,
NC00312,
NSC-759574,
IDI1_033777,
KS-000010A1,
NCGC00015380-01,
NCGC00015380-02,
NCGC00015380-03,
NCGC00015380-04,
NCGC00015380-05,
NCGC00015380-06,
NCGC00015380-07,
NCGC00015380-08,
NCGC00015380-10,
NCGC00015380-11,
NCGC00015380-12,
NCGC00015380-13,
NCGC00022882-03,
NCGC00024907-01,
NCGC00024907-02,
NCGC00024907-03,
NCGC00024907-04,
NCGC00024907-05,
NCGC00024907-06,
NCGC00024907-07,
NCGC00024907-08,
NCGC00261089-01,
AN-23421,
CAS_364-98-7,
CC-26456,
CPD000058392,
LS-40410,
SAM001246872,
SC-83321,
B6526,
D5402,
EU-0100404,
FT-0603087,
Z3125,
VU0239714-6,
2270-EP2281815A1,
2270-EP2295550A2,
2270-EP2301933A1,
2270-EP2308838A1,
2270-EP2311827A1,
C06949,
D00294,
EN300-122611,
32273-EP2281815A1,
32273-EP2298415A1,
32273-EP2301933A1,
32273-EP2305640A2,
32273-EP2311827A1,
364D987,
A823275,
C-13401,
I06-2041,
SR-01000075314-1,
SR-01000075314-3,
SR-01000075314-4,
SR-01000075314-6,
BRD-K73109821-001-05-2,
BRD-K73109821-001-10-2,
7-chloro-3-methyl-1,2,4-benzothiadiazine,1,1-dioxide,
Diazoxide, European Pharmacopoeia (EP) Reference Standard,
2H-1,2,4-Benzothiadiazine,7-chloro-3-methyl-, 1,1-dioxide,
4H-1,2,4-Benzothiadiazine, 7-chloro-3-methyl-, 1,1-dioxide,
7-chloro-3-methyl-4H-1|E?,2,4-benzothiadiazine-1,1-dione,
Diazoxide, United States Pharmacopeia (USP) Reference Standard,
7-chloranyl-3-methyl-4H-1$l^{6},2,4-benzothiadiazine 1,1-dioxide,
7-chloro-3-methyl-2H-1$l^{6},2,4-benzothiadiazine 1,1-dioxide,
7-chloro-3-methyl-4H-1$l;{6},2,4-benzothiadiazine-1,1-dione,
isoproterenol,
Isoprenaline,
D07WEP,
Diazoxide [USAN:BAN:INN],
C8-H7-Cl-N2-O2-S,
CID3019,
D003981,
2h-1,2,4-benzotiadiazina, 7-cloro-3-metil-, 1,1-dioxida,
7-Chloro-3-methyl-2H-benzo[e][1,2,4]thiadiazine 1,1-dioxide,
|
| Complexity | 360 |
| Compound Is Canonicalized | Yes |
| Covalently-Bonded Unit Count | 1 |
| Defined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Exact Mass | 229.992g/mol |
| Formal Charge | 0 |
| Heavy Atom Count | 14 |
| Hydrogen Bond Acceptor Count | 3 |
| Hydrogen Bond Donor Count | 1 |
| Isotope Atom Count | 0 |
| Molecular Weight | 230.666g/mol |
| Monoisotopic Mass | 229.992g/mol |
| Rotatable Bond Count | 0 |
| Topological Polar Surface Area | 66.9A^2 |
| Undefined Atom Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| XLogP3 | 1.2 |
| Symbol: | |
| Hazard Class | |
| Hazard statements | H302-H315-H319-H335-H350-H360 |
| Packing Group | |
| Precautionary statements | P261-P305+P351+P338 |
| UN Code |
| Chemical Name: | Batch Number: | |
| Chemical Structure: | CAS Registry No: | |
| Product ID: | ||
| Manufacture Date: | ||
| Storage Temperature: | ||
| Formula: | ||
| Molecular Weight: | ||
| Quantity: |
| Test: | Result: |

